<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <fn-group id="cei13284-ntgp-0501">
  <fn id="cei13284-note-0200">
   <p>
    <bold>OTHER ARTICLES PUBLISHED IN THIS REVIEW SERIES</bold>
   </p>
   <p>
    <italic>Vaccines for emerging pathogens: from research to the clinic. Part two. Clinical and Experimental Immunology 2019, 198: 141–142.</italic>
   </p>
   <p>
    <italic>A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens. Clinical and Experimental Immunology 2019, 198: 143–152.</italic>
   </p>
   <p>
    <italic>Formulation technologies for oral vaccines. Clinical and Experimental Immunology 2019, 198: 153–169.</italic>
   </p>
  </fn>
 </fn-group>
</notes>
